Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis

This study has been terminated.
(The decision was taken solely for business/administrative reasons, no safety considerations entered into this. Ongoing randomized patients to complete.)
Information provided by:
Axcan Pharma Identifier:
First received: November 17, 2009
Last updated: July 6, 2011
Last verified: July 2011
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: September 2011
  Estimated Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)